Zynix AI Scales Care Execution Agents to Nearly 1 Mn Patients Across Value-based Care Networks

The rollout spans organizations, including Palm Beach ACO, Eternal Health, NHS-affiliated programs, Innovacare, and Privia Health.

Zynix AI, a Florida-based healthtech company developing an AI-first platform for value-based care, has deployed its Care Execution Agents across leading accountable care organizations and health systems, reaching nearly one million patients and strengthening its role in enabling real-time care delivery within value-based care models.

The rollout spans organizations, including Palm Beach ACO, Eternal Health, NHS-affiliated programs, Innovacare, and Privia Health, reflecting growing demand for execution-focused digital health tools.

Zynix AI integrates data from electronic medical records, claims systems, and clinical workflows, enabling AI-driven agents to carry out tasks that typically require manual intervention. These include post-discharge follow-ups, scheduling annual wellness visits, monitoring chronic conditions such as hypertension and diabetes, and identifying and closing care gaps.

By embedding these capabilities into routine workflows, the platform aims to reduce administrative burden while improving patient adherence and care coordination.

"Healthcare doesn't need more dashboards--it needs execution," said Gautam, CTO of Zynix AI. "We're building the execution layer for healthcare, where AI agents don't just analyze data but actively help providers deliver care at scale."

The company’s adoption across accountable care organizations and integrated delivery networks highlights a growing appetite for AI tools that directly influence outcomes. Its ability to operate across fragmented data environments further supports its positioning as infrastructure within value-based ecosystems.

Alongside its deployment growth, Zynix AI has surpassed a valuation benchmark of over USD 100 Mn, driven by investor interest and expansion momentum. The company is currently engaging with strategic investors as it prepares for its next phase of scaling.

It is also increasing hiring across engineering, AI research, and product functions to accelerate development of its agent-based platform and expand into additional markets.

Stay tuned for more such updates on Digital Health News